Association between Testosterone/Estradiol Ratio and Risk of Cardiometabolic Diseases in Women at Menopause Transition Age

作者全名："Awadji, Fabrice Boris; Huang, Bi; Sasmita, Bryan Richard; Obiegbusi, Samuel Chigbo; Czika, Armin; Xue, Yuzhou; Luo, Suxin; Sowanou, Alphonse; Liu, Gang"

作者地址："[Awadji, Fabrice Boris; Huang, Bi; Sasmita, Bryan Richard; Xue, Yuzhou; Luo, Suxin; Liu, Gang] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing 400016, Peoples R China; [Obiegbusi, Samuel Chigbo] Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Chongqing 400060, Peoples R China; [Czika, Armin] Transilvania Univ Brasov, Res & Dev Inst, Fac Med, Brasov 500484, Romania; [Sowanou, Alphonse] Harbin Med Univ, Ctr Endem Dis Control, Chinese Ctr Dis Control & Prevent, Key Lab Etiol & Epidemiol, Harbin 150081, Heilongjiang, Peoples R China"

通信作者："Liu, G (通讯作者)，Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing 400016, Peoples R China."

来源：CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000906778300021

JCR分区：Q4

影响因子：0.2

年份：2022

卷号：49

期号：12

开始页：　

结束页：　

文献类型：Article

关键词：cardiometabolic diseases; testosterone; estradiol ratio; menopause transition; aging

摘要："Background: Imbalance of testosterone/estradiol ratio are frequently reported to be associated with the risk of cardiometabolic diseases; however, studies have yet to report the testosterone/estradiol ratio and its relationship to cardiometabolic diseases in women at menopause transition. This study aimed to explore the association between testosterone/estradiol ratio with cardiometabolic diseases in women during their menopausal transition age. Methods: 551 women aged from 45 to 55 years old were involved in this study. Their baseline information, disease comorbidity, blood biochemical tests, echocardiography and serum sex hormones were collected. Women were categorized by tertile distribution of testosterone/estradiol ratio. We used binary logistic regression model (for odds ratio) and poissoon loglinear model (for prevalence ratio) to evaluate the association between testosterone/estradiol ratio with cardiometabolic diseases. Results: The mean age of the study population was 48.6 +/- 3.5 years old. Taking testosterone/estradiol ratio < 3.9 as reference, the odds ratio with 95% confidence interval across the tertile groups for obesity were: 1.0 (reference), 2.32 (0.96-5.64), 4.70 (1.75-12.67) (p (for trend) = 0.002); for hypertension were: 1.0 (reference), 2.37 (1.45-3.86), 2.02 (1.12-3.62) (p (for trend) = 0.013); for cardiometabolic diseases were: 1.0 (reference), 2.29 (1.47-3.56), 2.34 (1.37-3.99) (p (for trend) = 0.013), compared with the prevalence ratio of 1.0 (reference), 1.64 (1.26- 2.15), 1.65 (1.21-2.23) (p (for trend) = 0.001), respectively. Conclusions: Higher testosterone/estradiol ratio was associated with elevated prevalence of cardiometabolic diseases in women at menopause transition period."

基金机构：cultivation fund of the First Affiliated Hospital of Chongqing Medical University [PYJJ2019-25]

基金资助正文："This study is supported by the cultivation fund of the First Affiliated Hospital of Chongqing Medical University, No. PYJJ2019-25."